These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25847221)

  • 21. Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.
    Bourque PR; Pringle CE; Cameron W; Cowan J; Chardon JW
    PLoS One; 2016; 11(8):e0159993. PubMed ID: 27490101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive respiratory care in patients with myasthenic crisis.
    Aggarwal AN; Gupta D; Behera D; Prabhakar S; Jindal SK
    Neurol India; 2002 Sep; 50(3):348-51. PubMed ID: 12391468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.
    Cortés-Vicente E; Álvarez-Velasco R; Segovia S; Paradas C; Casasnovas C; Guerrero-Sola A; Pardo J; Ramos-Fransi A; Sevilla T; López de Munain A; Gómez MT; Jericó I; Gutiérrez-Gutiérrez G; Pelayo-Negro AL; Martín MA; Mendoza MD; Morís G; Rojas-Garcia R; Díaz-Manera J; Querol L; Gallardo E; Vélez B; Albertí MA; Galán L; García-Sobrino T; Martínez-Piñeiro A; Lozano-Veintimilla A; Fernández-Torrón R; Cano-Abascal Á; Illa I
    Neurology; 2020 Mar; 94(11):e1171-e1180. PubMed ID: 32071167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis.
    Ando T; Omasa M; Kondo T; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Sonobe M; Date H
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):705-9; discussion 709. PubMed ID: 25618314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravis.
    Marulli G; Schiavon M; Perissinotto E; Bugana A; Di Chiara F; Rebusso A; Rea F
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):730-5; discussion 735-6. PubMed ID: 23312969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of clinical factors affecting outcome of myasthenia gravis.
    Yoshimoto Y; Ishida S; Hosokawa T; Arawaka S
    Muscle Nerve; 2021 Jul; 64(1):90-94. PubMed ID: 33885175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R; Treeprasertsuk S; Phanthumchinda K
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
    Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
    Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on 'Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry'.
    Su Z; Wang B; Ni J; Hu Y; Weng Y; Zhang X
    Eur J Neurol; 2017 Mar; 24(3):e17. PubMed ID: 28211243
    [No Abstract]   [Full Text] [Related]  

  • 35. Prethymectomy plasmapheresis in myasthenia gravis.
    Yeh JH; Chen WH; Huang KM; Chiu HC
    J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis.
    Watanabe A; Watanabe T; Obama T; Mawatari T; Ohsawa H; Ichimiya Y; Takahashi N; Kusajima K; Abe T
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):868-76. PubMed ID: 15001919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.
    Qureshi AI; Choudhry MA; Akbar MS; Mohammad Y; Chua HC; Yahia AM; Ulatowski JA; Krendel DA; Leshner RT
    Neurology; 1999 Feb; 52(3):629-32. PubMed ID: 10025801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.
    Yamada C; Pham HP; Wu Y; Cooling L; Kim HC; Morgan S; Schwartz J; Winters JL; Wong EC
    J Clin Apher; 2017 Feb; 32(1):5-11. PubMed ID: 26946363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark.
    Hansen JS; Danielsen DH; Somnier FE; Frøslev T; Jakobsen J; Johnsen SP; Andersen H
    Muscle Nerve; 2016 Jan; 53(1):73-7. PubMed ID: 25914186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.
    Forbes RB; Colville S; Swingler RJ;
    J Neurol; 2004 Jul; 251(7):813-7. PubMed ID: 15258782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.